Andere talen IPH Limited

Aandelen

Beurs gesloten - Australian S.E. Andere beurzen 08:10:50 11-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,4 ^AUD	-2,14%		+1,91%	-0,16%

13/05	Het aandeleninkoopplan van IPH Limited verlengd tot 30 mei 2025.	CI
08/05	IPH dient een voorstel in om QANTM Intellectual Property over te nemen	MT

IPH Extends Share Repurchase Program	13/05
IPH Limited's Equity Buyback Plan Extended till May 30, 2025.	13/05
Adamantem Capital Triumphs Over IPH in QANTM Bidding War	10/05
IPH Submits Proposal to Acquire QANTM Intellectual Property	08/05
IPH Joins QANTM Bidding War; QANTM Shares Up 6%	08/05
IPH Limited entered into non-binding indicative proposal to acquire QANTM Intellectual Property Limited for AUD 250 million.	08/05
IPH Limited Announces Executive Changes	29/02
IPH Managing Director Pares Shareholding in Firm	28/02
IPH Reports H1 FY24 Revenue Up 22%, EPS of AU$0.0879	21/02
IPH Ltd. Reports H1 FY24 Revenue Up 21% to AU$274.4 Million; Underlying Diluted EPS of AU$0.212	21/02
IPH Limited Reports Earnings Results for the Half Year Ended December 31, 2023	21/02
US FDA Ends Partial Clinical Hold on Innate Pharma's Investigational Cancer Drug	04/01
Sanofi Licenses Natural Killer Cell Engager Program from Innate Pharma	19/12
IPH Completes ROBIC Business Acquisition	18/12
IPH Limited completed the acquisition of ROBIC L.L.P.	15/12
IPH Announces Third Canadian Acquisition with AU$124 Million Deal	22/11
IPH Managing Director and CEO Sells Company Shares	22/11
IPH Limited entered into an agreement to acquire ROBIC L.L.P. for CAD 110 million.	20/11
IPH Limited Approves Election of Director, David Wiadrowski	15/11
IPH Limited Seeks Acquisitions	15/11

Geen resultaten voor deze zoekopdracht